Maosheng Cheng

Shenyang Pharmaceutical University — China

Chemistry · Physical Sciences

39h-index7.0kcitations551works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Catalytic Alkyne Reactions(43), Computational Drug Discovery Methods(38), Natural product bioactivities and synthesis(38), Catalytic C–H Functionalization Methods(32), Chemical Synthesis and Analysis(29)

Publications551 total

Correction: Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Journal of Nanobiotechnology·2025Open Access
Dispersion‐Enhanced Nitrogen‐Centered Photocatalysis of the Direct Hydrogen Atom Transfer
Angewandte Chemie International Edition·2025Open Access
Dispersion‐Enhanced Nitrogen‐Centered Photocatalysis of the Direct Hydrogen Atom Transfer
Angewandte Chemie·2025Open Access
Discovery of FBP1 as novel therapeutic target and asiatic acid-hydrogen sulfide donors accelerate diabetic wound healing
Journal of Advanced Research·2025Open Access
Pathway economy in cyclization of 1 <i>,n</i> -enynes
Beilstein Journal of Organic Chemistry·2025Open Access
Influence of homolog composition and hydration states of magnesium stearate on carrier-based dry powder formulations for inhalation
European Journal of Pharmaceutical Sciences·2025Open Access
Dispersion-Enhanced Nitrogen-Centered Photocatalysis of the Direct Hydrogen Atom Transfer
2025
Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors
Bioorganic Chemistry·2025· 1 cited
Patient’s knowledge, attitudes and behaviours towards pulmonary nodule management: a cross-sectional study in Wenzhou, China
BMJ Open·2025Open Access
Author correction to “Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors” [Acta Pharm Sin B 12 (2022) 952–966]
Acta Pharmaceutica Sinica B·2025Open Access
Design, Synthesis, and Computational Insights into PKMYT1 Inhibitors for the Treatment of Breast Cancer
Biomedicines·2025Open Access
Discovery of potent and selective PKMYT1 inhibitors for the treatment of CCNE1-amplified cancer
European Journal of Medicinal Chemistry·2025· 2 cited
Development of Hydrogen Sulfide-Donating Silybin Derivatives with a Type-2 Diabetes Mellitus-Alleviating Effect through Improving Intestinal L-Cell Functions
Journal of Medicinal Chemistry·2025
Silica Gel-Promoted Tryptamine-Ynamide Cyclization Strategy Enabling Total Synthesis of Elacomine
Organic Letters·2025
Unlocking the Potential of Ynamide as a Promoter in Copper(II)-Catalyzed <i>O</i>-Glycosylation
Organic Letters·2025
[Protective effect and its mechanism of diselenide cross-linked nano-loaded astaxanthin on gentamicin-induced vestibular toxicity in mice].
PubMed·2025
Gold(I)-Catalyzed Pathway-Switchable Syntheses of Azocine[4,5-<i>b</i>]indole and (1<i>H</i>-indol-3-yl)-Azepino[4,5-<i>b</i>]indole Derivatives
The Journal of Organic Chemistry·2025· 3 cited
Discovery of Highly Selective CYP1B1 Inhibitors
Journal of Medicinal Chemistry·2025· 3 cited
Rational design of CZL-S092: A novel indazole-based PLK4 inhibitor targeting neuroblastoma through virtual screening and fragment-based drug design strategies
European Journal of Medicinal Chemistry·2025· 1 cited
Identification of a p21-activated kinase 1 (PAK1) inhibitor with 10-fold selectivity against PAK2
Bioorganic & Medicinal Chemistry Letters·2025· 1 cited
page 1 of 28Next →

Frequent Co-authors

Zhonggui He(8), Jin Sun(7), Dongmei Zhao(7), Yang Liu(7), Chenzhou Hao(7), Bin Lin(6), Gaofei Wei(6), Feng Li(5), Yongxiang Liu(5), Liyu Zhao(5), Bingjun Sun(4), Shizhen Zhao(4), Jian Wang(4), Tianxiao Wu(4), Shiyi Zuo(3), Yeong Shik Kim(3), Zhuang Hou(3), Weijing Luan(3), Shanshan Cui(3), Xiangqian Zhang(3)